IPO・Exited

AccuRna, Inc.
Business outline
"Nucleic acid drug delivery system"
EXIT(2020)
WealthNavi Inc.
Business outline
Fully automated wealth management service
EXIT(2020)
QD Laser, Inc.
Business outline
”Silicon photonics and laser eyewear for low vision aid”
EXIT(2021)
Xenoma Inc.
Business outline
"Wearable device using flexible wiring"
EXIT(2022)
Modalis Therapeutics Corporation
Business outline
Drug development using proprietary technologies on CRISPR and protein engineering platforms
EXIT(2022)
Telexistence
Business outline
"Development of remote control and intelligent robot"
EXIT(2023)
Adriakaim Inc.
Business outline
Development of medical device for the treatment of acute myocardial infarction
EXIT(2023)
Aidemy Inc.
Business outline
AI online learning service / AI project support
EXIT(2023)
FIMECS, Inc.
Business outline
Development of drugs with a mechanism of action to induce proteolysis.
EXIT(2024)
Astroscale Holdings Inc.
Business outline
"Collection of space debris・On-Orbit-Services"
EXIT(2024)
Chordia Therapeutics Inc.
Cancer Drug Development (RNA dysregulation)
EXIT(2024)
Heartseed Inc.
Cardiac regenerative medicine using iPSCs
EXIT(2024)
Synspective Inc.
Business outline
"Development and operation of small SAR satellite"
EXIT(2024)
UrbanX Technologies, inc.
Establishment of realtime digital twin tool for inspection of road condition
EXIT(2025)
Axelspace Corporation
Business outline
"Development and operation of small optical satellite"
EXIT(2025)